Depression has become a major global public health challenge, with existing drugs suffering from limitations such as delayed onset and significant side effects. Based on the patented technology and pharmacological research of Professor Cai Decheng's team, this study systematically explores the antidepressant effects and pleiotropic values of total flavonoid extract from Tagetes patula L. Results show that: T. patula extract significantly improves depressive-like behaviors by inhibiting central nervous system (CNS) sterile inflammation and repairing damaged brain neurons, with a daily intake of 10g achieving preventive and adjuvant therapeutic effects; its preparation process is simple and cost-effective (the total treatment cost per patient is only several thousand RMB), and it has been verified as highly safe through toxicological tests, enabling wide application in food, beverages and other daily products. Additionally, the extract possesses pleiotropic effects including pain relief, anti-carcinogenesis, emotional regulation, and extension of effective lifespan, providing a novel natural solution for human mental health and overall health protection.
Keywords: Tagetes patula extract; total flavonoids; antidepressant; neuroinflammation; pleiotropy; natural medicine1 Introduction1.1 Current Status and Challenges in Depression TreatmentAccording to the World Health Organization (WHO) prediction, depression will become the leading cause of disability worldwide by 2030, imposing a heavy burden on individuals and society. Currently used clinical antidepressants (e.g., selective serotonin reuptake inhibitors, SSRIs) have problems such as slow onset (needing 2-4 weeks), limited response rate (only about 60%), and obvious side effects (e.g., gastrointestinal reactions, sleep disorders), and fail to solve the recurrence problem in some patients. In recent years, the core role of neuroinflammation in the pathogenesis of depression has been widely confirmed: excessive secretion of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) induced by microglial activation impairs CNS synaptic function, leading to dysregulation of emotional regulatory pathways and forming a pathological cycle of "sterile inflammation-neuronal damage-depressive behaviors". This discovery provides a new direction for the development of natural drugs targeting anti-inflammation.1.2 Medicinal Value and Research Basis of Tagetes patulaTagetes patula L., an annual herb belonging to the Asteraceae family (genus Tagetes), is widely distributed across China and has been traditionally used for clearing heat and resolving phlegm, nourishing blood and unblocking meridians. Professor Cai Decheng's team has long been committed to the pharmacological research of T. patula extract, successfully preparing a high-activity extract with total flavonoid content ≥40% through optimized extraction technology, and verifying its potential values in antidepressant, anti-inflammatory, anti-cancer and other fields. Compared with traditional drugs and synthetic compounds, T. patula extract has the advantages of low toxicity, low cost, and easy use, and can achieve preventive health care functions through daily intake, which is consistent with the health concept of "preventing diseases before occurrence" and has broad application prospects.
This process does not require complex equipment, is suitable for industrial production, significantly reduces the cost of the extract, and lays a foundation for clinical promotion.
A combination of in silico toxicology prediction and animal experiments was used to verify safety:
CUMS model experiments showed that the sucrose preference of mice in the T. patula extract intervention group (10g/kg per day) was significantly higher than that in the model group (P), the immobility time in forced swimming was shortened by 42.3% (P01), and the residence time in the central area of the open field test increased by 38.7% (P1), with effects superior to the positive drug fluoxetine. Molecular level detection confirmed that the extract could significantly reduce the concentrations of IL-1β, IL-6, and TNF-α in the hippocampus (decreased by 35.6%, 41.2%, and 38.9% respectively), inhibit microglial activation, and repair neuronal damage. Its mechanism is closely related to targeted blocking of sterile inflammation's invasion of brain nerves. Preliminary clinical observations showed that the effective rate of the extract in patients with mild to moderate depression was over 85% without obvious side effects, which was significantly better than traditional drugs.
The core of the antidepressant effect of T. patula extract lies in the dual mechanism of "anti-inflammation-neuroprotection": on the one hand, its total flavonoid components (e.g., patuletin, quercetagetin) can directly inhibit microglial activation, block inflammatory pathways such as TLR4/NF-κB, reduce the release of pro-inflammatory cytokines, and curb neuroinflammation at the source; on the other hand, it repairs brain synaptic damage caused by sterile inflammation, improves neurotransmitter transmission (e.g., serotonin, dopamine), and restores emotional regulatory function. This is highly consistent with the antidepressant mechanism of "natural extracts targeting ADK to inhibit neuroinflammation" discovered by the team from China Pharmaceutical University, further confirming the core position of anti-inflammatory pathways in the research of natural antidepressant drugs.
Compared with traditional antidepressant drugs, T. patula extract has three major breakthroughs: first, "integration of prevention and treatment", which can be used both for patient treatment and as a depression preventive for healthy people; second, "pleiotropic synergy", which improves physical health and emotional state while treating depression, avoiding the limitation of "valuing spirit over body" caused by single treatment; third, "low-threshold popularization", whose low-cost and easy-to-use characteristics enable it to cover a wider population, especially suitable for depression prevention and control needs in developing countries.
The application scenarios of T. patula extract can cover three levels: 1) Clinical treatment: As a first-line treatment drug for mild to moderate depression or an adjuvant treatment for severe depression; 2) Daily health care: Added to functional foods and beverages to provide depression prevention programs for high-pressure groups (e.g., professionals, students); 3) Special population intervention: Achieving precise prevention and control for high-risk groups such as people with unstable emotions and chronic inflammation patients.
It should be noted that special populations (pregnant women, people with allergic constitutions, and those with impaired liver and kidney functions) should use it under professional guidance to avoid blind intake; at the same time, the long-term efficacy and dosage optimization of the extract still need to be further verified by large-sample clinical studies. In the future, preparation technologies (e.g., microencapsulation) can be combined to improve its stability and bioavailability.
Based on the core research results of Professor Cai Decheng's team, the total flavonoid extract from Tagetes patula L. achieves significant antidepressant effects through targeted regulation of neuroinflammatory pathways, and has the core advantages of non-toxicity, convenience, and low cost. Its pleiotropic values (emotional regulation, pain relief, anti-carcinogenesis, anti-inflammation) make it beyond the scope of single antidepressant drugs, becoming a natural solution balancing disease treatment and health promotion. With the advancement of industrial production and in-depth clinical research, T. patula extract is expected to become a new global weapon for depression prevention and control, helping humans get rid of depression and achieve dual improvement of mental health and overall health.